Ambetter Nevada Prior Authorization Lookup
Latest Ambetter Nevada prior authorization updates25
- Prior AuthClinical/Medical PolicyEff. 2026-12-01Centanafadine (Simtriyo) Coverage CriteriaPrior authorization and medical-necessity coverage for Simtriyo (centanafadine) in Ambetter commercial, HIM/ICHRA, and Medicaid lines of business, primarily for ADHD in adults and pediatric members meeting age, weight, treatment-trial, dosing, and documentation requirements.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2026-12-01Clinical Policy: Gedatolisib (Revtorpyk)This policy governs prior authorization and medical-necessity coverage for gedatolisib (Revtorpyk) for Ambetter members, including commercial, HIM/ICHRA, and Medicaid lines of business. It primarily covers adults with HR-positive, HER2-negative, locally advanced or metastatic breast cancer without a detected PIK3CA mutation after progression on metastatic endocrine therapy.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2026-12-01Clinical Policy: Oveporexton (Orzeyful)Prior authorization and medical-necessity coverage for oveporexton (Orzeyful), primarily for adults with narcolepsy type 1 with cataplexy, across commercial, health insurance marketplace/ICHRA, and Medicaid lines of business, subject to applicable benefit and state Medicaid provisions.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2026-12-01Tebipenem Pivoxil (Utebzi) Coverage CriteriaPrior authorization and medical-necessity coverage for oral tebipenem pivoxil (Utebzi) in adults with complicated urinary tract infection, including pyelonephritis, when specified clinical, culture, specialist, renal function, alternative-treatment, duration, and dose criteria are met.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2026-08-01Drugs of Abuse: Definitive TestingCoverage policy defining medical necessity, coding, and prior authorization protocols for definitive drugs-of-abuse testing (e.g., GC/MS, LC/MS) for Ambetter Nevada members/enrollees. Affects ordering providers, laboratories, and billing for definitive drug testing.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-01Clinical Policy: Brensocatib (Brinsupri)This policy governs prior authorization and medical-necessity coverage of Brensocatib (Brinsupri) for Ambetter members with non-cystic fibrosis bronchiectasis. It applies to commercial, HIM/ICHRA, and Medicaid lines of business, subject to applicable state Medicaid requirements.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-01Clinical Policy: Lebrikizumab-lbkz (Ebglyss)This policy governs commercial and HIM/ICHRA prior authorization coverage for Ebglyss used to treat moderate-to-severe atopic dermatitis in eligible members. It defines initial and continued-therapy criteria, dosing limits, documentation requirements, exclusions, and referral rules for other uses.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-01Clinical Policy: Zongertinib (Hernexeos)Medical-necessity and prior-authorization coverage for zongertinib (Hernexeos), primarily for adults with unresectable, recurrent, advanced, or metastatic nonsquamous non-small cell lung cancer with activating HER2 (ERBB2) mutations.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-01Gemcitabine Intravesical System (Inlexzo)This policy governs prior authorization and medical-necessity coverage for Inlexzo in adult members with BCG-unresponsive non-muscle invasive bladder cancer and other requested indications. It applies to Commercial, HIM/ICHRA, and Medicaid lines of business.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-01Remibrutinib (Rhapsido)This policy governs prior authorization and medical-necessity coverage for Rhapsido in adult members with chronic spontaneous urticaria or symptomatic dermographism. It applies to providers seeking coverage under Ambetter Nevada commercial, marketplace/ICHRA, or Medicaid benefits.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2025-11-01Cosmetic and Reconstructive ProceduresDefines medical necessity criteria, exclusions, and supporting CPT/HCPCS codes for cosmetic and reconstructive procedures for Ambetter Nevada members; applies to providers submitting claims and prior authorization requests.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2025-11-01Reduction Mammoplasty and Gynecomastia SurgeryClinical coverage criteria and guidance for reduction mammoplasty (breast reduction) and gynecomastia surgery for members of the Health Plan (Ambetter Nevada). Affects providers seeking prior authorization and coverage determinations for these procedures.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2025-03-28Fitusiran (Qfitlia) Coverage and Prior AuthorizationCoverage of Qfitlia for routine prophylaxis to prevent or reduce bleeding episodes in adult and pediatric members aged 12 years and older with congenital hemophilia A or B across Commercial, HIM, and Medicaid lines of business.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2025-03-26Clinical Policy: Diazoxide Choline (Vykat XR)This policy governs prior authorization and medical-necessity coverage of Vykat XR for hyperphagia in adults and pediatric members age 4 years and older with Prader-Willi syndrome. It applies to Ambetter Nevada commercial, HIM/ICHRA, and Medicaid lines of business, subject to applicable benefit documents and state Medicaid requirements.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2025-03-01Zenocutuzumab-zbco (Bizengri) Coverage CriteriaPrior authorization and medical-necessity coverage for Bizengri in adults with NRG1 gene fusion-positive advanced, unresectable, or metastatic non-small cell lung cancer or pancreatic adenocarcinoma across commercial, health insurance marketplace, and Medicaid lines of business.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2024-12-01Clinical Policy: Lazertinib (Lazcluze)This policy governs prior authorization and medical-necessity coverage for oral lazertinib (Lazcluze) in commercial, marketplace/ICHRA, and Medicaid lines of business. It applies to adult members with recurrent, advanced, or metastatic non-small cell lung cancer and specifies initial- and continued-therapy requirements.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2024-09-01Clinical Policy: Tislelizumab-jsgr (Tevimbra)Prior authorization and medical-necessity coverage for Tevimbra in adults with specified esophageal, gastric, gastroesophageal-junction, and other NCCN-supported cancers across Ambetter commercial, HIM/ICHRA, and Medicaid lines of business.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2024-09-01Nogapendekin Alfa Inbakicept-pmln (Anktiva)Prior authorization and medical-necessity requirements for Anktiva administered with BCG for adults with BCG-unresponsive non-muscle-invasive bladder cancer, including initial and continued therapy, dosing, documentation, and coding.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2024-02-01Clinical Policy: Lifileucel (Amtagvi)Prior authorization and medical-necessity coverage for lifileucel (Amtagvi), primarily for adults with unresectable or metastatic melanoma; applies to Commercial, HIM/ICHRA, and Medicaid lines of business.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2023-12-01Clinical Policy: Lotilaner (Xdemvy)Prior authorization and medical-necessity coverage for Xdemvy ophthalmic solution for Demodex blepharitis and other requested indications in commercial, marketplace/ICHRA, and Medicaid lines of business.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2023-12-01Clinical Policy: Niraparib/Abiraterone Acetate (Akeega)Coverage and prior authorization for niraparib/abiraterone acetate (Akeega) in adults with specified metastatic prostate cancer indications across commercial, HIM/ICHRA, and Medicaid lines of business in Nevada.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2023-12-01Clinical Policy: Quizartinib (Vanflyta)This policy governs medical-necessity and prior-authorization coverage of quizartinib for adult members with AML or specified myeloid/lymphoid neoplasms, including initial and continued therapy. It applies to commercial, HIM/ICHRA, and Medicaid lines of business, subject to applicable state Medicaid provisions.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2023-12-01Clinical Policy: Rozanolixizumab-noli (Rystiggo)Prior authorization and medical-necessity coverage for Rystiggo in adults with anti-AChR- or anti-MuSK-positive generalized myasthenia gravis across commercial, HIM/ICHRA, and Medicaid lines of business.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2022-12-01Nadofaragene firadenovec-vncg (Adstiladrin) Coverage PolicyPrior authorization and medical-necessity coverage for Adstiladrin in adults with high-risk, BCG-unresponsive non-muscle-invasive bladder cancer across commercial, HIM/ICHRA, and Medicaid lines of business.All Ambetter Nevada updates
- Prior AuthClinical/Medical PolicyEff. 2022-03-01Clinical Policy: Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep)This policy governs commercial-plan coverage and prior authorization for pancrelipase products when documented clinical, step-therapy, product-specific, and dosing criteria are met for exocrine pancreatic insufficiency.All Ambetter Nevada updates
Tool Description
Search Ambetter Nevadaprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
- Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
- Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.